טוען...
Reimbursement for Continuous Glucose Monitoring
Continuous glucose monitoring (CGM) systems have been available for more than 15 years by now. However, market uptake is relatively low in most countries; in other words, relatively few patients with diabetes use CGM systems regularly. One major reason for the reluctance of patients to use CGM syste...
שמור ב:
| הוצא לאור ב: | Diabetes Technol Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mary Ann Liebert, Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4717510/ https://ncbi.nlm.nih.gov/pubmed/26784130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2015.0296 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|